Details
Stereochemistry | ACHIRAL |
Molecular Formula | C28H33N3O9S2.ClH |
Molecular Weight | 656.167 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CCCCOC(=O)COC1=C(CCNS(=O)(=O)C2=CC(=CC=C2O)C(=N)NO)C=CC(=C1)C3=C(C=CC=C3)S(C)(=O)=O
InChI
InChIKey=GFSMSIHRCHISJI-UHFFFAOYSA-N
InChI=1S/C28H33N3O9S2.ClH/c1-3-4-15-39-27(33)18-40-24-16-20(22-7-5-6-8-25(22)41(2,35)36)10-9-19(24)13-14-30-42(37,38)26-17-21(28(29)31-34)11-12-23(26)32;/h5-12,16-17,30,32,34H,3-4,13-15,18H2,1-2H3,(H2,29,31);1H
Molecular Formula | C28H33N3O9S2 |
Molecular Weight | 619.706 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | ClH |
Molecular Weight | 36.461 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 11:47:28 GMT 2023
by
admin
on
Sat Dec 16 11:47:28 GMT 2023
|
Record UNII |
GA433E4LRU
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Code | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
GA433E4LRU
Created by
admin on Sat Dec 16 11:47:28 GMT 2023 , Edited by admin on Sat Dec 16 11:47:28 GMT 2023
|
PRIMARY | |||
|
135443381
Created by
admin on Sat Dec 16 11:47:28 GMT 2023 , Edited by admin on Sat Dec 16 11:47:28 GMT 2023
|
PRIMARY | |||
|
409358-98-1
Created by
admin on Sat Dec 16 11:47:28 GMT 2023 , Edited by admin on Sat Dec 16 11:47:28 GMT 2023
|
PRIMARY | |||
|
KFA-1982
Created by
admin on Sat Dec 16 11:47:28 GMT 2023 , Edited by admin on Sat Dec 16 11:47:28 GMT 2023
|
PRIMARY | KFA-1982(951785-02-7) |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
Class: Antithrombotic; Mechanism of Action: Factor Xa inhibitor; Highest Development Phases: Phase I Deep vein thrombosis, Thrombosis; Most Recent Events: 01 Oct 2003 Phase-I clinical trials in Thrombosis in Japan (PO), 01 Oct 2003 Phase-I clinical trials in Thrombosis in Europe (PO)
|
||
|
ACTIVE MOIETY |
Many polymorphs of KFA-1982, an orally active factor Xa (fXa) inhibitor, have been identified and their physicochemical properties have been investigated. Form B was selected as the oral API form because of its superior stability and solubility characteristics. The hydrochloride salt was selected for the API because of good stability.
|